Compare BNR & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | PDYN |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Wholesale Distributors |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.5M | 164.8M |
| IPO Year | 2019 | 2020 |
| Metric | BNR | PDYN |
|---|---|---|
| Price | $13.00 | $3.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 23.4K | ★ 1.0M |
| Earning Date | 11-23-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,246,000.00 |
| Revenue This Year | $101.46 | $389.07 |
| Revenue Next Year | $14.81 | $50.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.79 | $2.66 |
| 52 Week High | $41.72 | $10.00 |
| Indicator | BNR | PDYN |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 42.87 |
| Support Level | $9.12 | N/A |
| Resistance Level | $19.10 | $4.14 |
| Average True Range (ATR) | 1.26 | 0.36 |
| MACD | 0.16 | 0.06 |
| Stochastic Oscillator | 88.67 | 56.47 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.